Surrey Heartlands

Joint Formulary & PAD

Testosterone - Low sexual desire in menopausal women

You are here : Home > Formulary Search > Testosterone - Low sexual desire in menopausal women

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Gel
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important

Prescribe generically as "Testosterone 2% transdermal gel 60g".

See PAD for further information and resources.

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

Documents :
 
Evidence Review
Testosterone gel for low libido - Evidence review - May 2017
Patient resource
Patient Information Leaflet - Testosterone off-label use in women (Womens Health Concern)
Information
Clinician information leaflet - Testosterone off-label use in menopause (British Menopause Society)
 

Status 2

Non Formulary
Formulations :
  • Gel
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :
Important

Testavan and Testogel do NOT deliver suitable doses for this indication

Prescribe as testosterone 2% transdermal gel (off-label use)

 

Status 3

Non Formulary
Formulations :
  • Cream
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :
Important

Androfeme is unlicensed in the UK. Other products can be used off-label

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Testosterone
Indication :
Low sexual desire in menopausal women
Group Name :
Keywords :
reduced sex drive, low sex drive, reduced sexual function, female sexual dysfunction, hypoactive sexual desire disorder, low libido
Brand Names Include :
Androfeme, Testavan, Testogel, Tostran
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Testosterone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Low sexual desire in menopausal women.

Committee Recommendations (4)

11 Sep 24 - Surrey Heartlands Medicines Safety Committee (MSC)

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

07 Feb 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Health System Area Prescribing Committee (APC) has agreed that topical testosterone should be prescribed generically, ideally using Drug Tariff descriptions.

06 Dec 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approved a change in traffic light status from BLUE to GREEN for testosterone gel.

The following testosterone products are NON-FORMULARY as they are either unlicensed in the UK or not available in biologically appropriate doses for the indication: Androfeme, Testogel, Testavan

Please note; Testim has been discontinued.

04 Oct 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed that treatment of low sexual desire in menopausal women with testosterone 1% cream will be given a NON-FORMULARY traffic light status.

Androfeme 1% cream is unlicensed in the UK and there are licensed testosterone preparations available that are being used off-label.